Skip to main content
. 2020 Dec 22;13(1):3. doi: 10.3390/pharmaceutics13010003

Figure 4.

Figure 4

Clinical manufacturing approaches to produce exosome-based therapeutics. Large-scale good manufacturing practice (GMP)-exosome production under GMP-compliant procedures to ensure the quality, safety and consistency. EVs: Extracellular vesicles.